Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIQ

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > UP 50%

<< Previous

Bullboard Posts

Next >>

Post by bigkaganon Apr 01, 2020 3:00pm

338 Views

Post# 30869448

UP 50%

since Mar.23. Only 2 weeks left for FDA to decide. If pot stores are deemed essential why not also allow a safe oipiod like Aximiris to calm nerves in this tense period, hee

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army